Obscure Disease Returns
Less antibiotic use linked to dangerous throat disease
By Robert Preidt HealthScout Reporter
"The message from our
work and other bits and pieces is … a very small
proportion of patients who present with sore throats do
have conditions which, if untreated with antibiotics, can
be very life-threatening." -- Terry Riordan,
microbiologist, Public Health Laboratory Service, England
SOURCES: Interviews with Wynne Jones, Ph.D., and Terry
Riordan, M.B, B.Chir., consultant medical microbiologists,
Public Health Laboratory Service, England; New Scientist
press release |
SUNDAY, Jan. 21 (HealthScout) -- A renewed
caution against using antibiotics for sore throats may have
revived a potentially fatal disease that had almost vanished,
British researchers say. Lemierre's disease, fairly common in
the early 20th century, was essentially eradicated with the
introduction of antibiotics. But a recent surge in the disease
has been discovered by Wynne Jones and Terry Riordan,
consultant medical microbiologists with the Public Health
Laboratory Service in southwestern England.
"We haven't seen it, and suddenly we saw three
cases within a few months," says Jones, who's based in
Taunton.
So she and Riordan collected six years of
records from eight public health laboratories in southwestern
England and found 11 other cases of Lemierre's disease. All
were successfully treated.
The disease, caused by the bacterium
Fusobacterium necrophorum, affects young, healthy adults. The
first symptom is a sore throat, but the bacteria later travel
into the blood, infecting the lungs, liver and joints. It can
be fatal if not treated with antibiotics.
While they say they have no proof, Jones and
Riordan suspect the reemergence of Lemierre's may be linked to
the trend of not prescribing antibiotics for sore throats.
Most sore throats are caused by viruses, which
are immune to antibiotics. And doctors know that the use of
antibiotics in those cases only encourages the bacteria's
resistance to the antibiotics.
"In the old days, they were quite liberal in
treating sore throats with antibiotics, and that's likely why
Lemierre's disappeared," Jones says. "And now, because of
antibiotic resistance, people are being far more cautious with
prescribing antibiotics."
"Certainly, in this country, there is heavy
pressure on doctors, particularly those in general practice,
not to use antibiotics for treating sore throats," says
Riordan, who's based in Exeter.
"The message from our work and other bits and
pieces is … a very small proportion of patients who present
with sore throats do have conditions which, if untreated with
antibiotics, can be very life threatening," he says.
Riordan says Lemierre's is not a wide-spread
threat.
"It's unquestionably a small thing. It's never
going to have a huge public health impact. It would be quite
wrong to give that impression, but it is worth raising
awareness about this," he says.
The increase in Lemierre's is not an argument
against the campaign to reduce antibiotic use because the
advantages far outweigh the risks, the researchers say.
"Overall, there is benefit in restricting the
use of antibiotics, but there is that small potential for an
occasional patient to have an adverse effect from delayed
therapy," Riordan says.
Both researchers suggest doctors consider
antibiotics for people who have sore throats that don't get
better after several days, or for those who have other
symptoms, including fever and swollen lymph nodes.
They say Lemierre's can be a challenge for
doctors and other health professionals because it's no longer
mentioned in the major medical textbooks and is an almost
forgotten disease.
"A number of microbiologists were unaware of
the condition until we mentioned it to them. They'd never seen
a case of it, never heard of it," Riordan says.
"We're just starting to raise the profile so
we don't overlook this condition," Jones says.
|